Literature DB >> 3701106

Toxin involvement in toxic shock syndrome.

B A Crass, M S Bergdoll.   

Abstract

Cultures for Staphylococcus and sera from 434 individuals with confirmed or probable toxic shock syndrome (TSS) were studied. Three hundred forty-eight (91.6%) of the staphylococcal isolated produced TSS toxin-1 (TSST-1) alone or in combination with one or more staphylococcal enterotoxins. Isolates producing both staphylococcal enterotoxin C and TSST-1 had a higher association with nonmenstrual and fatal cases than did any other toxin combination. The sera of 284 patients with TSS were tested for antibodies to TSST-1, and 234 (82.4%) had no detectable level of antibody compared with 80 (77.7%) of 103 healthy controls having antibody levels of greater than or equal to 1:800. The sera from patients with TSS also had lower levels of antibody to staphylococcal enterotoxins A, B, and C than did the controls, a result indicating that these subjects may have an immunodeficiency that inhibits the production and/or maintenance of antibodies to the staphylococcal enterotoxins and TSST-1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3701106     DOI: 10.1093/infdis/153.5.918

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Diversity of toxic shock syndrome toxin 1-positive Staphylococcus aureus isolates.

Authors:  John E Warner; Andrew B Onderdonk
Journal:  Appl Environ Microbiol       Date:  2004-11       Impact factor: 4.792

Review 2.  Streptococcal toxic shock syndrome in children.

Authors:  D Floret; D Stamm; P Cochat; P Delmas; W Kohler
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

3.  Steady-state staphylococcal enterotoxin type C mRNA is affected by a product of the accessory gene regulator (agr) and by glucose.

Authors:  L B Regassa; J L Couch; M J Betley
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

4.  Determination by western blot (immunoblot) of seroconversions to toxic shock syndrome (TSS) toxin 1 and enterotoxin A, B, or C during infection with TSS- and non-TSS-associated Staphylococcus aureus.

Authors:  J L Whiting; P M Rosten; A W Chow
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

5.  Production of toxic shock syndrome toxin 1 by Staphylococcus aureus restricted to endogenous air in tampons.

Authors:  R F Reiser; S J Hinzman; M S Bergdoll
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

6.  Nonproduction of toxic shock syndrome toxin 1 by coagulase-negative staphylococci.

Authors:  J Parsonnet; A E Harrison; S E Spencer; A Reading; K C Parsonnet; E H Kass
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

7.  V beta 11+ T-lymphocyte expansion by toxic shock syndrome toxin-1 differs in mice bearing H-2q versus H-2b haplotypes.

Authors:  Y X Zhao; U Brunsberg; R Holmdahl; A Tarkowski
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

8.  Production of toxic shock syndrome-like illness in rabbits by Staphylococcus aureus D4508: association with enterotoxin A.

Authors:  B D McCollister; B N Kreiswirth; R P Novick; P M Schlievert
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

9.  [Special features of intensive care of toxic shock syndrome. Review and case report of a TSST-1 associated toxic-shock syndrome with adult respiratory distress syndrome and multiple organ failure from a staphylococcal panaritium].

Authors:  C Lang; H Behnke; J Bittersohl; L Eberhart; E Walthers; F Sommer; H Wulf; G Geldner
Journal:  Anaesthesist       Date:  2003-09       Impact factor: 1.041

10.  Toxin involvement in methicillin-resistant Staphylococcus aureus enteritis in gastroenterological surgery.

Authors:  Y Takesue; T Yokoyama; T Kodama; T Santou; A Nakamitsu; Y Murakami; Y Imamura; K Miyamoto; M Okita; H Tsumura
Journal:  Gastroenterol Jpn       Date:  1991-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.